Journal of Clinical Medicine · Nov 15, 2026
Microbiota-Directed Interventions for Metabolic Syndrome, Obesity, Type 2 Diabetes, Hypertension, and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Overview of Registered Clinical Trials
By Belančić A, Scarlata GGM, Fajkić A et al.
Cardiometabolic diseases, including metabolic syndrome, obesity, type 2 diabetes, hypertension, and metabolic dysfunction-associated steatotic liver disease (MASLD), represent major global health challenges, with gut microbiota emerging as a potential modifiable contributor to their pathophysiology. This review aimed to characterize the current landscape of microbiota-directed interventions and identify trends, research priorities, and knowledge gaps in clinical development across cardiometabolic disorders. We conducted an overview of registered clinical trials evaluating microbiota-directed interventions, including probiotics, prebiotics, synbiotics, and faecal microbiota transplantation, in adults with metabolic syndrome, obesity or overweight, type 2 diabetes, arterial hypertension or MASLD. Nine eligible trials were identified, comprising 554 planned participants. Most were randomized placebo-controlled studies, but the clinical development landscape remained predominantly early-stage and characterized by modest sample sizes. MASLD was the most frequently investigated indication, while other cardiometabolic conditions were comparatively underrepresented. Across trials, substantial heterogeneity was observed in intervention strategies, treatment duration, and primary outcome frameworks, with limited incorporation of direct microbiome or microbial-metabolite measurements. Overall, microbiota-directed interventions should currently be regarded as experimental therapeutic strategies whose clinical value remains to be established. Future progress will require completed, adequately powered multicentre randomized controlled trials, greater standardization of interventions and outcome frameworks, direct assessment of biological target engagement, and sufficiently long follow-up.